NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for microgram


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States
2009 SEP 14 ... Actelion Pharmaceuticals US, Inc., announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis , for the treatment of New York Heart ...
Subject: Hypertension
Price: $3.00
*
Alimera Reports Safety and Efficacy Results From the 18-Month Interim Readout of the Human PK Iluvien(R) Study
2009 OCT 12 ... patient variability, the trends continue to be consistent with our expectations that sub microgram levels of corticosteroids will benefit this population," said Ken Green, Ph.D., chief ...
Subject: Pharmaceuticals
Price: $3.00
*
Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society OTS Meeting
2009 NOV 16 ... (LNPs), where the median effective dose (ED50) for gene silencing was achieved at microgram/kilogram dose levels. Further, quantitation of siRNA revealed the ability to achieve ...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
2009 NOV 23 ... strides in our delivery research efforts and are now on a trajectory to achieve single microgram/kilogram gene silencing potency. Also, while our focus remains on therapeutic ...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Data Presented on Cempra Pharmaceutical's CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
2009 NOV 9 ... America. CEM-101 demonstrated 100% coverage (100% inhibition at less than or equal to 1 microgram/ml) against these strains. Activity was slightly better than telithromycin (MIC90 of ...
Subject: Drug Resistance
Price: $3.00
*
New pancreas data have been reported by scientists at Autonomous University
2009 AUG 31 ... in relatively thick tissue sections, map trace elements at the Cellular level to the microgram per gram (dry weight) level, and extract quantitative information on these elements," ...
Subject: Pancreas
Price: $3.00
*
New Start-up Enavail Applies Proprietary Particle Engineering Technologies To Increase Drug Solubility, Stability and Bioavailability
2009 NOV 23 ... offers custom, economical solutions to partners from initial drug screening (even microgram quantities) through to cGMP manufacturing of materials for clinical trials. Business ...
Subject: Enavail
Price: $3.00
*
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
2009 NOV 1 ... and pregnancy both increase the risk for a poor immune response to the normal 15-microgram dose of seasonal influenza vaccine given to the general population," says NIAID ...
Subject: NIH/National Institute of Allergy and Infectious Diseases
Price: $3.00
*
NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
2009 NOV 1 ... trials of 2009 H1N1 influenza vaccines in healthy adults have shown that a single 15-microgram dose of 2009 H1N1 influenza vaccine without adjuvant is well tolerated and induces a ...
Subject: NIH/National Institute of Allergy and Infectious Diseases
Price: $3.00
*
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
2009 NOV 2 ... related the drug itself. The study also found that POT-4 deposits form at doses of 450 microgram and greater and that the higher the concentration was the longer the deposits lasted. ...
Subject: Pharmaceuticals
Price: $3.00
*
Reports outline DNA research research from H. Takahashi and colleagues
2009 SEP 21 ... in amplifying one copy of a circular DNA molecule more than 10(12)-fold to give microgram quantities of amplification product without using submicroliter reaction volumes. ...
Subject: DNA Research
Price: $3.00
*
Reports summarize cytokines study results from X.Y. Liang and co-researchers
2009 OCT 5 ... LPS-induced TNF from bone marrow-derived macrophages (BMDMs). Fractionation yielded microgram quantities of a protein that was identified by MS to be hemopexin (Hx). Mouse Hx ...
Subject: Cytokines
Price: $3.00
*
Research from University of Valencia has provided new information about liquid chromatography
2009 AUG 24 ... used in water treatment allowed the selective quantification of residual EDA at low microgram per milliliter levels of concentration without off-line preconcentration.." ...
Subject: Liquid Chromatography
Price: $3.00
*
Research reports from A.J. Thompson and co-authors provide new insights into enzyme research
2009 AUG 31 ... tagging chemistries was enabled by a novel hybrid proteomic method to isolate low-microgram (10-30 mu g) membrane raft protein preparations as unresolved bands in a low-density ...
Subject: Enzyme Research
Price: $3.00
*
Statement by Dr. Anthony Fauci, Director, National Institute of Allergy and Infections Diseases, NIH, Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults
2009 SEP 28 ... immune response in most healthy adults when administered in a single unadjuvanted 15-microgram dose. We congratulate the companies on these trials, which are an important part of the ...
Subject: U.S. Department of Health and Human Services HHS
Price: $3.00
*
Studies from Chulalongkorn University provide new data on reproduction research
2009 NOV 17 ... (15-35 micrometer) were visualized by fluorescein isothiocyanate labeled dextran ( 5 microgram/ml). The vascular response to acetylcholine ( Ach; 10(-5)M, 5 ml/5 min) was accessed ...
Subject: Reproduction Research
Price: $3.00
*
Studies from Yale University provide new data on microscopy
2009 OCT 6 ... isotopic labelling are required. For structural analysis of large soluble proteins in microgram quantities, an increasingly powerful method that does not require crystallization is ...
Subject: Microscopy
Price: $3.00
*
Variation Biotechnologies Flu Vaccine Provides Robust Immune Response, Broad Protection against H1N1 Influenza Strain
2009 SEP 28 ... model of influenza infection in humans, were studied. The first group received a 200 microgram intramuscular inoculation of Variation's SFV2/NAM1 vaccine on day zero, with a booster ...
Subject: Variation Biotechnologies, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login